Stock listing
LSE:0HNC BioMarin Pharmaceutical Inc. Share Price
UK listing (LSE) of BioMarin Pharmaceutical Inc. · home listing NASDAQ:BMRN
Follow BioMarin Pharmaceutical Inc. into a list and get an email when it puts out news.
Share price · LSE:0HNC
$60.51 USD -1.49 (-2.4%)
Close on Nov 20, 2026
- Day range
- $60.16 – $62.50 USDNov 20, 2026
- Volume
- 330 sharesNov 20, 2026
- 52-week range
- $49.39 – $70.85 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $82,511 USDMedian day 328 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BMRN · Home | $60.41 USD | -1.02 (-1.7%) | 6,062,417 | $61.53 | $62.01 | $59.84 | $61.43 | Close on Nov 20, 2026 |
| Frankfurt:BM8 | €56.12 EUR | -1.20 (-2.1%) | 194 | €55.52 | €56.18 | €55.52 | €57.32 | Close on Nov 20, 2026 |
| B3:B1MR34 | 157.60 BRL | 0.00 (0.0%) | — | 157.60 | 157.60 | 157.60 | 157.60 | Close on Nov 19, 2026 |
| LSE:0HNC | $60.51 USD | -1.49 (-2.4%) | 330 | $60.16 | $62.50 | $60.16 | $62.00 | Close on Nov 20, 2026 |
| Munich:BM8 | €55.49 EUR | +1.61 (+3.0%) | — | €55.49 | €55.49 | €55.49 | €53.88 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · LSE:0HNC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $55.57 | -1.22 | -2.1% | $55.18 | $55.93 | $55.00 | 1,635 | |
| $56.79 | +0.20 | +0.4% | $58.00 | $58.00 | $56.57 | 689 | |
| $56.59 | +1.511 | +2.7% | $59.12 | $59.12 | $55.54 | 1,056 | |
| $55.08 | -3.071 | -5.3% | $55.81 | $55.81 | $52.00 | 19,675 | |
| $58.15 | -0.04 | -0.1% | $58.89 | $59.51 | $57.71 | 421 | |
| $58.19 | +1.23 | +2.2% | $58.40 | $59.06 | $57.80 | 981 | |
| $56.96 | +1.30 | +2.3% | $56.80 | $57.00 | $56.01 | 1,006 | |
| $55.66 | +0.20 | +0.4% | $56.03 | $56.20 | $54.85 | 637 | |
| $55.46 | -0.48 | -0.9% | $56.00 | $56.04 | $55.46 | 4,456 | |
| $55.94 | +0.30 | +0.5% | $56.50 | $56.80 | $55.41 | 2,829 | |
| $55.64 | -0.68 | -1.2% | $57.20 | $57.20 | $55.27 | 461 | |
| $56.32 | +0.502 | +0.9% | $55.02 | $56.32 | $55.02 | 1,868 | |
| $55.82 | -0.273 | -0.5% | $56.30 | $57.08 | $55.58 | 358 | |
| $56.09 | +1.52 | +2.8% | $55.22 | $56.09 | $55.20 | 90 | |
| $54.57 | -0.13 | -0.2% | $54.50 | $55.26 | $53.90 | 173 | |
| $54.70 | -2.02 | -3.6% | $56.56 | $57.00 | $54.70 | 1,324 | |
| $56.72 | +1.698 | +3.1% | $55.56 | $57.58 | $55.56 | 276 | |
| $55.02 | +0.782 | +1.4% | $54.40 | $55.39 | $54.38 | 271 | |
| $54.24 | -1.528 | -2.7% | $56.00 | $56.00 | $53.94 | 392 | |
| $55.77 | +0.928 | +1.7% | $55.33 | $56.41 | $55.04 | 407 | |
| $54.84 | +0.12 | +0.2% | $55.00 | $55.63 | $54.51 | 282 | |
| $54.72 | -0.16 | -0.3% | $55.62 | $55.62 | $53.92 | 348 | |
| $54.88 | -1.14 | -2.0% | $56.10 | $56.60 | $54.88 | 279 | |
| $56.02 | -1.69 | -2.9% | $57.51 | $58.47 | $55.78 | 807 | |
| $57.71 | +0.02 | 0.0% | $57.50 | $57.90 | $56.92 | 254 | |
| $57.69 | -1.35 | -2.3% | $58.52 | $59.20 | $57.48 | 288 | |
| $59.04 | -1.57 | -2.6% | $61.19 | $61.19 | $58.84 | 575 | |
| $60.61 | +1.15 | +1.9% | $58.70 | $60.67 | $58.70 | 2,217 | |
| $59.46 | +0.10 | +0.2% | $59.46 | $59.85 | $59.02 | 619 | |
| $59.36 | -1.14 | -1.9% | $59.80 | $61.35 | $58.82 | 626 | |
| $60.50 | -0.71 | -1.2% | $60.50 | $61.66 | $60.50 | 368 | |
| $61.21 | -1.09 | -1.7% | $62.47 | $63.00 | $61.20 | 243 | |
| $62.30 | -1.72 | -2.7% | $63.50 | $65.05 | $62.00 | 371 | |
| $64.02 | -0.24 | -0.4% | $64.34 | $65.00 | $63.53 | 16,632 | |
| $64.26 | -0.429 | -0.7% | $64.86 | $65.60 | $64.08 | 146 | |
| $64.69 | -1.091 | -1.7% | $65.39 | $66.35 | $64.65 | 267 | |
| $65.78 | +0.95 | +1.5% | $64.60 | $66.00 | $64.00 | 295 | |
| $64.83 | +0.61 | +0.9% | $65.87 | $65.87 | $64.00 | 148 | |
| $64.22 | -2.44 | -3.7% | $66.42 | $67.00 | $64.18 | 304 | |
| $66.66 | +1.134 | +1.7% | $67.00 | $67.00 | $65.82 | 234 | |
| $65.53 | +0.366 | +0.6% | $65.64 | $65.64 | $65.46 | 251 | |
| $65.16 | +0.28 | +0.4% | $64.00 | $65.38 | $64.00 | 270 | |
| $64.88 | -0.29 | -0.4% | $64.01 | $65.26 | $63.67 | 125 | |
| $65.17 | -1.20 | -1.8% | $65.00 | $66.50 | $64.11 | 260 | |
| $66.37 | 0.00 | 0.0% | $66.37 | $66.37 | $66.37 | 0 | |
| $66.37 | -0.26 | -0.4% | $65.50 | $66.51 | $65.50 | 263 | |
| $66.63 | +0.23 | +0.3% | $67.20 | $67.50 | $66.46 | 963 | |
| $66.40 | +1.43 | +2.2% | $64.11 | $66.48 | $64.11 | 636 | |
| $64.97 | +0.57 | +0.9% | $65.92 | $65.97 | $64.67 | 266 | |
| $64.40 | -0.81 | -1.2% | $64.81 | $66.36 | $64.08 | 234 | |
| $65.21 | -0.98 | -1.5% | $65.33 | $65.80 | $64.88 | 212 | |
| $66.19 | +0.03 | 0.0% | $66.01 | $66.31 | $65.14 | 95 | |
| $66.16 | +0.99 | +1.5% | $65.00 | $67.00 | $65.00 | 237 | |
| $65.17 | -1.51 | -2.3% | $66.46 | $66.80 | $64.80 | 8,930 | |
| $66.68 | -1.21 | -1.8% | $67.00 | $68.34 | $66.64 | 253 | |
| $67.89 | -1.02 | -1.5% | $70.00 | $70.00 | $67.63 | 308 |
- Ticker
- LSE:0HNC
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- USD
What changed lately
Latest news release · Nov 4, 2026
BioMarin to Participate in Upcoming Investor Conferences
Latest earnings call · Nov 2, 2026
BioMarin Pharmaceutical (NASDAQ:BMRN) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 2, 2026
Q3 2026 Earnings Presentation
Earnings · 24 slides
Calls
Replays
BioMarin Pharmaceutical (NASDAQ:BMRN) Q3 2026 Earnings Call
Mon, Nov 02, 2026 · 4:30 PM ET
Watch TranscriptBioMarin Pharmaceutical (NASDAQ:BMRN) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 4:30 PM ET
Watch TranscriptBioMarin Pharmaceutical (NASDAQ:BMRN) Q1 2026 Earnings Call
Mon, May 04, 2026 · 4:30 PM ET
Watch Transcript
Latest news
BioMarin to Participate in Upcoming Investor Conferences
Nov 4, 2026
Closed $56.59 (+2.7%) on Nov 4, 2026
BioMarin Reports Third Quarter 2026 Financial and Operating Results
Nov 2, 2026
Closed $55.08 (-5.3%) on Nov 3, 2026
BioMarin Enters Into Exclusive Worldwide License Agreement With GC Biopharma and Hanmi Pharm for Investigational Next-Generation Enzyme Replacement Therapy, Adding a Second Potential Treatment for Fabry Disease
Oct 29, 2026
Closed $56.96 (+2.3%) on Oct 29, 2026
BioMarin to Host Third Quarter 2026 Financial Results Conference Call and Webcast on Monday, November 2, 2026, at 4: 30pm ET
Oct 26, 2026
Closed $55.94 (+0.5%) on Oct 26, 2026
BioMarin Presents New Data Advancing Understanding of Achondroplasia and Hypochondroplasia Treatment at the American Society for Bone and Mineral Research Annual Meeting
Oct 9, 2026
Closed $54.84 (+0.2%) on Oct 9, 2026
BioMarin Appoints Cara Bauer as Chief People Officer
Oct 5, 2026
Closed $56.02 (-2.9%) on Oct 6, 2026
BioMarin Announces Five-Year Phase 3 Data for POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at World Muscle Society Annual Congress
Oct 2, 2026
Closed $57.71 (0.0%) on Oct 5, 2026
BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors
Sep 14, 2026
Closed $66.66 (+1.7%) on Sep 14, 2026
BioMarin Announces Positive Results of Phase 3 VOXZOGO® (vosoritide) Study in Hypochondroplasia Published in NEJM Evidence
Sep 9, 2026
Closed $64.88 (-0.4%) on Sep 9, 2026
BioMarin Announces Close of the Alesta Therapeutics Acquisition
Sep 1, 2026
Closed $64.97 (+0.9%) on Sep 1, 2026
Financings
5.500% senior unsecured notes due 2034
Feb 12, 2026
Closed: US$850M raised
Use of proceeds: With term loans and cash, to fund the pending acquisition of Amicus Therapeutics and related fees and expenses
Announced Jan 26, 2026 · Update Jan 29, 2026 · Closed Feb 12, 2026
Decks
Q3 2026 Earnings Presentation
Earnings · 24 slides · Nov 2, 2026
Jefferies Healthcare Conference 2026
Conference · 15 slides · November 2026
Q2 2026 Earnings Presentation
Earnings · 28 slides · Aug 6, 2026
Q1 2026 Earnings Presentation
Earnings · 21 slides · May 4, 2026
BioMarin Pharmaceutical Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 39 in the last 12 months · 241 in all · newest Nov 4, 2026 · oldest 2019
- Calls
- 27 calls with a replay · 27 with a transcript · latest Nov 2, 2026
- Decks
- 66 decks · latest Nov 2, 2026
Where BioMarin Pharmaceutical Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BMRN · Home listing | NASDAQ | United States | USD |
| gettex:BM8 | gettex | Germany | EUR |
| Tradegate:BM8 | Tradegate | Germany | EUR |
| LS Exchange:924801 | LS Exchange | Germany | EUR |
| Frankfurt:BM8 | Frankfurt | Germany | EUR |
| BMV:BMRN | BMV | Mexico | MXN |
| Lang & Schwarz:924801 | Lang & Schwarz | Germany | EUR |
| B3:B1MR34 | B3 | Brazil | BRL |
| LSE:0HNC · This page | LSE | United Kingdom | USD |
| Milan:1BMRN | Milan | Italy | EUR |
| BX Swiss:BM8 | BX Swiss | Switzerland | CHF |
| EUROTLX:4BMRN | EUROTLX | Italy | EUR |
| Munich:BM8 | Munich | Germany | EUR |
| VIE:BMRN | Vienna | Austria | EUR |
| BOATS:BMRN | BOATS | United States | USD |
| Dusseldorf:BM8 | Dusseldorf | Germany | EUR |
| Hamburg:BM8 | Hamburg | Germany | EUR |
| Hanover:BM8 | Hanover | Germany | EUR |
| Stuttgart:BM8 | Stuttgart | Germany | EUR |
| BIVA:BMRN | BIVA | Mexico | MXN |
Log in to ask 6ix AI your own questions about BioMarin Pharmaceutical Inc.